Advertisement

Health


Telix Pharmaceuticals to raise $200m for final stage prostate cancer therapy trials

Telix Pharmaceuticals to raise $200m for final stage prostate cancer therapy trials

Melbourne-headquartered nuclear medicine company Telix Pharmaceutic...

Trajan Group is on a mission to democratise healthcare, one merger at a time

Trajan Group is on a mission to democratise healthcare, one merger at a time

Since listing on the ASX in mid-2021, analytical sciences company T...

UK private equity firm CapVest enters race for IVF giant Virtus Health with $649m bid

UK private equity firm CapVest enters race for IVF giant Virtus Health with $649m bid

Assisted reproductive services multinational Virtus Health (ASX: VR...

Bod to launch UK clinical trial into medicinal cannabis efficacy on long COVID

Bod to launch UK clinical trial into medicinal cannabis efficacy on long COVID

With an estimated 1.3 million people in the United Kingdom sufferin...

Ramsay Health Care to acquire UK mental health services provider for $1.4 billion

Ramsay Health Care to acquire UK mental health services provider for $1.4 billion

Australian healthcare giant Ramsay Health Care (ASX: RHC) has today...

Advertisement
Advertisement
Advertisement
Starpharma shares plunge as UK sales paused over promotional claim concerns

Starpharma shares plunge as UK sales paused over promotional claim concerns

Pharmaceutical company Starpharma (ASX: SPL) and its retail partn...

Vitamins subscription healthtech Vitable nourished by $5.5m Series A raise

Vitamins subscription healthtech Vitable nourished by $5.5m Series A raise

A Sydney-based online platform for vitamin supplement subscriptio...

Are 3D-printed COVID tests the tip of the iceberg for Australian medical device manufacturing?

Are 3D-printed COVID tests the tip of the iceberg for Australian medical device manufacturing?

Australia's high labour costs have traditionally made it toug...

FDA rejuvenates Avita Medical burns treatment

FDA rejuvenates Avita Medical burns treatment

Avita Medical Inc. (ASX: AVH) has received a big shot in the arm ...

Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug

Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug

Investors in Melbourne-based digital cognitive assessment technol...

ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

Earlier this year a Byron Bay-based company achieved a milestone ...

Could new findings put Mesoblast back in the COVID treatment race?

Could new findings put Mesoblast back in the COVID treatment race?

After four months in the doldrums due to its COVID-19 treatment i...

AnteoTech launches 15-minute COVID-19 test in Europe

AnteoTech launches 15-minute COVID-19 test in Europe

Brisbane-based biotech firm AnteoTech (ASX: ADO) has officially l...

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics (ASX: ECS) has submitted plans to the Office of Drug...

Creso Pharma appoints director of US business after New York legalises marijuana

Creso Pharma appoints director of US business after New York legalises marijuana

Australian medicinal cannabis company Creso Pharma (ASX: CPH) has...

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Stem cell therapeutics company Cynata's (ASX: CYP) pool of el...

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Pharmaceuticals manufacturer Starpharma (ASX: SPL) will commence ...

New US trial finds AstraZeneca vaccine 79 per cent effective

New US trial finds AstraZeneca vaccine 79 per cent effective

A Phase III trial of the AstraZeneca vaccine in the US has demons...

Advertisement

Partner Content

'Digitisation' and 'digitalisation' are two words t...
With the ongoing supply chain crisis expected to continue throughou...
From COVID-19 restrictions changing the way people shop, to supply ...
The last two years have delivered major disruption to the technolog...
If you are not reassessing how your organisation remunerates and re...
Three new qualifications at The University of Notre Dame Australia ...
Property developer Aspen Group has begun work to breathe new life i...
Golf Journeys, an Australian golf travel company, has big plan...
Advertisement